STK11IP

STK11IP (LIP1) is a leucine-rich repeat scaffold protein that integrates LKB1/AMPK, TGFβ/SMAD, and mTORC1/lysosome signaling axes. It was originally identified as a cytoplasmic anchor for the LKB1 kinase: co-expression shifts LKB1 from the nucleus to the cytoplasm, and STK11IP self-oligomerizes to scaffold a ternary LKB1–STK11IP–SMAD4 complex in which LKB1 phosphorylates SMAD4-Thr77, thereby suppressing SMAD4 binding to TGFβ/BMP-responsive promoters and inhibiting epithelial–mesenchymal transition (PMID:11741830, PMID:20974850). At the lysosome, STK11IP is phosphorylated at Ser404 by mTORC1 and binds V-ATPase to regulate lysosomal acidification; its genetic ablation increases autophagy flux, establishing STK11IP as a lysosome-specific mTORC1 effector that restrains autophagy (PMID:35365663). STK11IP also directly inhibits PTEN phosphatase activity to activate Akt signaling, promoting pathological cardiac hypertrophy in mouse models of pressure overload (PMID:33486894).

1. 2001 High

   The identity of LKB1-interacting partners that control its localization was unknown; discovery of LIP1/STK11IP as a leucine-rich repeat protein that retains LKB1 in the cytoplasm established the first mechanism for regulated LKB1 subcellular distribution and linked it to SMAD4 via a ternary complex.

   Evidence Co-immunoprecipitation, subcellular imaging after co-expression, Xenopus ectopic axis assay, and ternary complex pulldown

   PMID:11741830

   Open questions at the time

   • Endogenous stoichiometry and physiological triggers for LKB1 cytoplasmic retention were not determined
   • Functional consequence of the SMAD4 interaction on transcription was not addressed in this initial study
2. 2010 High

   How LKB1 regulates TGFβ signaling through STK11IP was resolved: LKB1 phosphorylates SMAD4 on Thr77 within the DNA-binding domain, disrupting promoter occupancy and thereby negatively regulating TGFβ/BMP-driven transcription and EMT, with STK11IP serving as the obligate scaffold via self-oligomerization.

   Evidence In vitro kinase assay with site-directed mutagenesis, promoter-binding assays, transcriptional reporter assays, co-immunoprecipitation

   PMID:20974850

   Open questions at the time

   • Whether STK11IP scaffolding is rate-limiting for SMAD4 phosphorylation in vivo is untested
   • Relevance to Peutz–Jeghers syndrome tumor suppression has not been directly demonstrated
3. 2021 Medium

   Whether STK11IP has LKB1-independent signaling roles was unclear; demonstration that STK11IP directly inhibits PTEN phosphatase activity to activate Akt signaling identified a distinct pro-hypertrophic function in the heart.

   Evidence STK11IP knockout mice subjected to isoproterenol/TAC-induced hypertrophy, in vitro PTEN phosphatase activity assay, co-immunoprecipitation

   PMID:33486894

   Open questions at the time

   • Molecular basis of PTEN inhibition (binding site, stoichiometry) is uncharacterized
   • Whether this PTEN-inhibitory function occurs outside cardiac tissue is unknown
   • Single-lab finding; independent replication is lacking
4. 2022 High

   STK11IP's relationship to mTORC1 and lysosomal biology was unknown; identification of STK11IP as a lysosome-specific mTORC1 substrate (Ser404) that binds V-ATPase and controls lysosomal acidification repositioned the protein as a direct autophagy suppressor downstream of mTORC1.

   Evidence Quantitative phosphoproteomics, lysosome proteome cross-referencing, genetic knockout in cells and mice, V-ATPase co-immunoprecipitation, autophagy flux assays

   PMID:35365663

   Open questions at the time

   • How phospho-Ser404 alters STK11IP–V-ATPase binding or V-ATPase assembly is mechanistically undefined
   • Structural basis of the STK11IP–V-ATPase interaction is lacking
   • Whether lysosomal and cytoplasmic LKB1-scaffolding functions of STK11IP are coordinated or independent is unresolved

• A unified model integrating STK11IP's lysosomal mTORC1-effector role, cytoplasmic LKB1-scaffolding role, and PTEN-inhibitory role — and whether these functions are spatially or temporally segregated — remains to be constructed.
• No structural model of STK11IP exists
• The relationship between STK11IP oligomerization and its distinct partner interactions is unexplored
• Tissue-specific versus universal functions of STK11IP are not delineated